Skip to main content
. 2012 Sep 6;13(5):198–214. doi: 10.1120/jacmp.v13i5.3856

Table 7.

Comparison in passing rates (%) among RTQA2‐measured and TPS‐calculated dose distributions and MatriXX dose distributions with “entire correction” for IMRT (iPlan MC) and VMAT (Eclipse AAA) plans. Gamma evaluation was performed with 3% dose difference and 3 mm DTA.

Plan No. RTQA2 and TPS RTQA2 and MatriXX MatriXX and TPS
1 (VMAT) 95.7 96.1 98.6
2 (VMAT) 98.5 94.6 99.1
3 (IMRT) 96.0 95.4 99.8
4 (IMRT) 96.0 95.8 99.2
5 (IMRT) 97.3 95.5 95.4
6 (IMRT) 96.6 94.8 99.6